Jonsson Comprehensive Cancer Center

7:07

For more information on Dr. Timothy Cloughesy's research or the UCLA Department of Neurology Brain Tumor Program please go to http://www.neurooncology.ucla.edu

2:51

Kevin Carlberg overcame a brain tumor (glioblastoma) thanks to a dendritric cell vaccine developed at UCLA's Jonsson Comprehensive Cancer Center and the care of his physician, Dr. Linda Liau.

UPDATE 8/31/2009: Kevin Carlberg suffered a recurrence of his cancer and, despite treatment, he passed away on Saturday, August 29, 2009. Through his participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Carlberg lived about four times longer than the average glioblastoma patient. His participation also helped move cancer research forward. We thank him.

4:20

Meet cancer patients and family members touched by new therapies developed at UCLA's Jonsson Cancer Center. Features appearances by Ryan Seacrest, Khloe Kardashian and the Kardashian family, Denise and Peter Wittich, Laura Felkai, and Meritt Carlberg, the widow of cancer patient Kevin Carlberg.

UPDATE: Laura Felkai suffered a recurrence of her cancer and, despite treatment, she passed away in June, 2011 Through her participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Felkai lived longer and enjoyed a better quality of life than the average melanoma patient. Her participation also helped move cancer research forward. We thank her.

1:39

Jonsson Cancer Center researcher Dr. Roger Lo was awarded a three-year, $750,000 Innovative Research Grant from Stand Up to Cancer. Here he talks about his melanoma research.

2:56

Jonsson Comprehensive Cancer Center's Dr. Dennis Slamon and his "dream team" of researchers are profiled for CBS 2 News Central. He discusses how pioneering research at UCLA is shaking up traditional methods in breast cancer therapy, targeting and tailoring treatment for patients by cancer subtype.

10:55

Antoni Ribas, M.D. of the UCLA Jonsson Comprehensive Cancer Center is involved in trials testing new cancer drugs targeting the cell surface molecule called PD-L1, and the immune cell receptors PD1. Early data from these trails involving non-small cell lung cancer, renal cancer and melanoma have demonstrated impressive results that can lead to new treatments for the disease. In the video interview, Dr. Ribas explains the trial test data published so far, and previews new data to be seen at the upcoming American Society of Clinical Oncology (ASCO) meeting.

4:49

Dr. Judith Gasson, Director of UCLA's Jonsson Comprehensive Cancer Center (JCCC), discusses research areas within the JCCC that are making tremendous headway in cancer treatment and detection. Advancements in stem cell research, nanotechnology, imaging, and translational research at the JCCC are making measurable progress and saving lives every day. To learn more about the JCCC, visit www.cancer.ucla.edu.

9:38

Drs. Judith Gasson, Lauren Pinter-Brown, Rich Finn and Antoni Ribas discuss research advances at UCLAs Jonsson Comprehensive Cancer Center. Three patients share their stories of battling cancer. This video was produced and directed by filmmaker Lawrence Kasdan. The music was composed by Grammy Award winner James Newton Howard.

UPDATE: Darrell Cantor suffered a recurrence of his cancer and, despite treatment, he passed away on Saturday, August 24, 2009. Through his participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Cantor lived longer and enjoyed a better quality of life than the average liver cancer patient. His participation also helped move cancer research forward. We thank him.

Advertisement